Sentact Names Dr. Nicholas Testa as First Chief Clinical Officer

Audio By Carbonatix

NASHVILLE, Tenn.--(BUSINESS WIRE)--Jan 27, 2026--

Sentact, a leader in healthcare technology, analytics, and services reimagining the path to exceptional care, today announced the appointment of Nicholas Testa, MD, as the company’s Chief Clinical Officer.

With nearly 20 years of experience in healthcare, Dr. Testa has extensive knowledge of enhancing clinical operations and improving patient outcomes. A proven leader in driving safety, quality, and patient experience improvements at scale, Dr. Testa will play a pivotal role on the executive leadership team, assisting in shaping the strategy for the business as a whole and representing the voice of the clinical leader.

“Nick is a standout leader in healthcare and with a successful track record of improving clinical operations through industry best practices, he’ll be instrumental as Sentact continues to reimagine the path to exceptional care,” said Daniel Hart, CEO of Sentact. “As our new Chief Clinical Officer, Nick will serve as the backbone of the clinical vision at Sentact to help our partners drive meaningful improvements and clinical excellence across their organizations.”

In his new role, Dr. Testa will leverage his clinical experience to support Sentact’s product and services portfolio, overseeing initiatives designed to advance clinical quality and safety and align the organization’s integrated platform with real life clinical workflows.

"I’m honored to join Sentact at such a pivotal moment for the healthcare industry, as hospitals and health systems face increasing clinical and operational complexity,” said Dr. Testa. “What truly differentiates Sentact is the depth of the team and the way our products and services come together to provide actionable insights across an organization. I look forward to collaborating with our partners to enhance performance, strengthen safety, and achieve better outcomes for the communities they serve.”

Prior to Sentact, Testa held several positions at CommonSpirit Health, a non-profit health system comprised of approximately 140 hospitals and over 2,300 care clinics, most recently serving as the company’s Regional Chief Medical Officer in California. He also previously served as Chief Physician Executive at Dignity Health, Chief Medical Officer at Providence St. Joseph Medical Center, and Associate Medical Director at LAC+USC Medical Center. Dr. Testa holds the title for Adjunct Voluntary Professor at USC where he continues to teach undergraduates, medical students and residents in the disciplines of safety, quality, process improvement and physician leadership.

The addition of Dr. Testa to Sentact’s leadership team follows the company’s recent announcement of two strategic acquisitions advancing safety at scale, building on its ongoing commitment to delivering measurable improvements in patient safety and care quality. Learn more about how Sentact is working to drive safety at scale here: www.sentact.com/patient-safety.

About Sentact

Sentact is reimagining the path to exceptional care for hospitals and health systems by powering the mission-critical safety, quality, and patient experience initiatives that enhance outcomes. With unmatched technology, analytics, and services, Sentact’s end-to-end solutions and proven expertise drive value across clinical operations, empowering healthcare leaders to transform insights into action and achieve measurable improvements and better patient outcomes organization-wide. For more information, visit sentact.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260127540167/en/

CONTACT: Tiffany Keenan

Greenough Communications

[email protected]

KEYWORD: TENNESSEE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SOFTWARE DATA ANALYTICS GENERAL HEALTH HEALTH DATA MANAGEMENT HEALTH TECHNOLOGY PROFESSIONAL SERVICES TECHNOLOGY

SOURCE: Sentact

Copyright Business Wire 2026.

PUB: 01/27/2026 09:00 AM/DISC: 01/27/2026 09:00 AM

http://www.businesswire.com/news/home/20260127540167/en